$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Vertex Pharmaceuticals: A Long-Term Growth Monster
03:23am, Monday, 21'st Oct 2024
Vertex Pharmaceuticals has a virtual monopoly in treating cystic fibrosis, having created and brought to market a function cure for 90% of the CF population. Their pipeline outside of CF has shown gre
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly sele
Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride
04:09am, Friday, 18'th Oct 2024
Vertex's diverse pipeline, including Casgevy for SCD, suzetrigine for chronic pain, and the vanzacaftor triple for CF, positions it for growth despite launch challenges. Casgevy's complex treatment pr
Vertex to Announce Third Quarter 2024 Financial Results on November 4th
04:05pm, Thursday, 10'th Oct 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, November 4, 2024 after the financial markets close. The comp
New Strong Buy Stocks for October 7th
07:16am, Monday, 07'th Oct 2024
ADMA, VERX, TRGP, EBMT and TALO have been added to the Zacks Rank #1 (Strong Buy) List on October 7, 2024.
New Acquisitions Could Be Big For Vertex Stock As Shares Score Breakout
03:04pm, Friday, 04'th Oct 2024
Corporate tax compliance software Vertex stock scores a breakout amid an array of acquisitions, as earnings growth begins to accelerate.
Best Growth Stocks to Buy for October 3rd
04:56am, Thursday, 03'rd Oct 2024
VERX, CARG, and UL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 3, 2024.
Vanguard Group Inc's Strategic Acquisition of Vertex Inc Shares
04:03pm, Wednesday, 02'nd Oct 2024
On September 30, 2024, Vanguard Group Inc, a prominent investment firm, expanded its portfolio by acquiring an additional 334,189 shares of Vertex Inc (VERX, Financial), a leading tax technology provi
Scoop up These 4 GARP Stocks to Receive Handsome Returns
11:06am, Wednesday, 02'nd Oct 2024
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. RACE, VERX, RMD and HUBB are some stocks that hold promise.
Vertex (VERX) Upgraded to Strong Buy: Here's What You Should Know
01:00pm, Tuesday, 01'st Oct 2024
Vertex (VERX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Vertex Energy Initiates Bankruptcy Proceedings, Shares Plunge
06:31am, Friday, 27'th Sep 2024
VTNR enters a Restructuring Support Agreement, supported by $80M Debtor-in-Possession financing, to continue day-to-day operations.
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the first accepted medical presentations of the Phase 3 data on the investigational once daily vanzacaftor/t
Vertex Energy and Its Lenders Initiate Formal Pathway Aimed at Achieving Sustainable Capital Structure
06:48pm, Tuesday, 24'th Sep 2024
HOUSTON--(BUSINESS WIRE)--Vertex Energy, Inc. (NASDAQ: VTNR) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, today announced it entered into a R
4 GARP Stocks to Scoop up for Maximum Returns
12:51pm, Tuesday, 17'th Sep 2024
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, RACE and VERX are some stocks that hold promise.
Investors Are Underestimating The Potential Of Vertex's Non-Addictive Pain Drug
01:59pm, Sunday, 15'th Sep 2024
Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than placebos
Sign In
Buy VERX